Kevin P. Madauss
GlaxoSmithKline (United States) · 81 works · 2,471 citations · h-index 22
Top works
- Structural Analyses Reveal Phosphatidyl Inositols as Ligands for the NR5 Orphan Receptors SF-1 and LRH-1
- Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
- Structure of neurolysin reveals a deep channel that limits substrate access
- A Ligand-mediated Hydrogen Bond Network Required for the Activation of the Mineralocorticoid Receptor
- Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064
- A Structural and in Vitro Characterization of Asoprisnil: A Selective Progesterone Receptor Modulator
- Progesterone Receptor Ligand Binding Pocket Flexibility: Crystal Structures of the Norethindrone and Mometasone Furoate Complexes
- Crystallization of protein–ligand complexes
- Conformationally constrained farnesoid X receptor (FXR) agonists: Heteroaryl replacements of the naphthalene
- The evolution of progesterone receptor ligands
- Discovery of non-steroidal mifepristone mimetics: Pyrazoline-based PR antagonists
- Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064
- Design and x-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptor
- FXR agonist activity of conformationally constrained analogs of GW 4064
- The first X-ray crystal structure of the glucocorticoid receptor bound to a non-steroidal agonist
- Pyrrolidinyl pyridone and pyrazinone analogues as potent inhibitors of prolyl oligopeptidase (POP)
- Conformationally constrained farnesoid X receptor (FXR) agonists: Alternative replacements of the stilbene
- The human ACC2 CT-domain C-terminus is required for full functionality and has a novel twist
- 2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6,7,8,9-tetrahydropyrido[2′,3′:4,5]thieno[2,3-b]pyridine derivatives as selective progesterone receptor agonists
- Generation and Characterization of Human Steroidogenic Factor 1 LBD Crystals with and without Bound Cofactor Peptide